Upgrade to SI Premium - Free Trial

Cycurion Reports First Quarter 2026 Results

May 14, 2026 8:30 AM

MCLEAN, Va., May 14, 2026 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU) ("Cycurion" or the "Company"), a leader in AI-driven cybersecurity and national security solutions with trusted relationships across the U.S. Government, numerous leading corporations, and high-profile individuals across all industries, announced today results for the first quarter ended March 31, 2026.

"The first quarter of 2026 marks a clear inflection point in our transformation," said Kevin Kelly, Chairman and Chief Executive Officer of Cycurion. "We nearly doubled gross margins, significantly reduced operating expenses and executed binding agreements to acquire Halo Privacy and HavenX, which adds approximately $7 million in annualized contracted revenues at approximately 55% gross margin once the deal closes. Combined with our existing contracted backlog, which we expect to deliver approximately $15 million to $17 million in annual revenue, the addition of Halo Privacy and HavenX will increase our contracted backlog we estimate to convert to revenue in a one year period to approximately $21 million to $22 million. We are executing with discipline - exiting lower margin legacy work, reducing costs and reinvesting in our AI-driven platforms. I am confident in our path to profitability and long-term shareholder value."

Highlights of First Quarter 2026 as Compared to Fourth Quarter 2025

Strategic and Operational Momentum

About Cycurion

Based in McLean, Virginia, Cycurion (NASDAQ: CYCU) is a forward-thinking provider of IT cybersecurity solutions and AI, committed to delivering secure, reliable, and innovative services to clients worldwide. Specializing in cybersecurity, program management, and business continuity, Cycurion harnesses its AI-enhanced ARx platform and expert team to empower clients and safeguard their operations. Along with its subsidiaries, Axxum Technologies LLC, Cloudburst Security LLC, and Cycurion Innovation, Inc., Cycurion serves government, healthcare, and corporate clients committed to securing the digital future. For more information, visit www.cycurion.com.

About Halo Privacy

Halo Privacy, with more than 10 years of expertise, develops cutting-edge, privacy-first secure communication tools engineered for the highest security standards, including the revolutionary Halo Link app.

About HavenX

HavenX is a leading digital investigations and attribution firm focused on cyber-harassment, defamation tracking, OSINT, IP geolocation, breach intelligence, and high-confidence threat actor identification.

Forward-Looking Statements

This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to the operations and prospective growth of Cycurion's business.

Certain statements in this press release that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Exchange Act of 1934, as amended. Any statements contained in this press release that are not statements of historical fact may be deemed forward-looking statements. Such statements include, but are not limited to, statements regarding the proposed transaction contemplated by the binding agreement, including the likelihood, timing, structure or consummation of the transaction; the anticipated benefits of the transaction; the acceleration of the Company's inorganic growth strategy; the continued execution on the Company's backlog; and other statements that are not historical facts, including statements which may be accompanied by words such as "continue," "will," "may," "could," "should," "expect," "expected," "plans," "intend," "anticipate," "believe," "estimate," "predict," "potential," and similar expressions are intended to identify such forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside the control of Cycurion and are difficult to predict. Examples of such risks and uncertainties include, but are not limited to, risks related to customer performance and satisfaction, contract modifications, delays or terminations, and the Company’s ability to fulfill contractual obligations, the outcomes of the Company's investigations, any potential legal proceedings, or the future performance of the Company's stock. Additional factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements can be found in the most recent annual report on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K filed by Cycurion with the U.S. Securities and Exchange Commission. Cycurion anticipates that subsequent events and developments may cause its plans, intentions, and expectations to change. Cycurion assumes no obligation, and it specifically disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as expressly required by law. Forward-looking statements speak only as of the date they are made and should not be relied upon as representing Cycurion's plans and expectations as of any subsequent date.

Cycurion Investor Relations:
(888) 341-6680
[email protected]

Cycurion Media Relations:
(888) 341-6680
[email protected]


Quarterly Results of Operations and Non-GAAP Financial Measures
(Unaudited)
Quarterly Consolidated Results of Operations
For the Three Months Ended
March 31, 2026 December 31, 2025 March 31, 2025
Revenue$3,268,620 $3,542,644 $3,870,050
Cost of revenue 2,580,262 3,114,505 3,192,287
Gross profit 688,358 428,139 677,763
Gross margin 21.1% 12.1% 17.5%
Operating expenses:
Selling, general and administrative expenses 2,743,695 4,013,876 337,374
Stock compensation expenses 315,833 804,424
Business combination expenses 630,000 10,437,894
Total operating expenses 3,059,528 5,448,300 10,775,268
Operating loss (2,371,170) (5,020,161) (10,097,505)
Interest income 14,236 25,768
Interest expense (204,852) (257,174) (178,890)
Gain on debt settlement, net (28,504) 141,653
Other expense (113,744)
Other expense, net (190,616) (259,910) (150,981)
Loss before income taxes (2,561,786) (5,280,071) (10,248,486)
Provision for income tax
Net loss (2,561,786) (5,280,071) (10,248,486)
Less: Net loss attributable to non-controlling interest 433,324 175,017
Net loss attributable to Cycurion$(2,128,462) $(5,105,054) $(10,248,486)


Reconciliation of Net Loss to EBITDA (Non-GAAP) and Adjusted EBITDA (Non-GAAP)
For the Three Months Ended
March 31, 2026 December 31, 2025 March 31, 2025
Net loss attributable to Cycurion$(2,128,462) $(5,105,054) $(10,248,486)
Interest income (14,236) (25,768)
Interest expense 204,852 257,174 178,890
Other expense 113,744
Depreciation and amortization 1,187 7,665 74,892
EBITDA (Non-GAAP) (1,936,659) (4,865,983) (9,880,960)
Loss on debt settlement, net 28,504 (141,653)
Transaction related expenses 630,000 10,437,894
Finance expense 100,000
Stock-based compensation 315,833 904,424
Adjusted EBITDA (Non-GAAP)$(1,620,826) $(3,303,055) $515,281


CYCURION, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Unaudited)
March 31, 2026 December 31, 2025
Assets:
Cash and cash equivalents$2,028,718 $5,255,235
Accounts receivable, net 3,336,047 2,687,479
Prepaid expenses and other current assets 106,934 60,133
Total current assets 5,471,699 8,002,847
Software development costs, net 4,735,981 4,606,981
Goodwill 21,238,450 20,842,508
Total non-current assets 25,974,431 25,449,489
Total assets$31,446,130 $33,452,336
Liabilities and Stockholders' Equity:
Liabilities:
Bank loan-revolving credit line$2,725,546 $2,933,396
Loans payable - current portion 669,693 669,693
Factoring liability 1,566,887 1,511,678
Convertible notes 192,897 192,897
Promissory notes 2,500,849 2,499,662
Loans payable - related parties 123,650 123,650
Accounts payable 1,441,596 1,314,772
Accrued liabilities 4,283,045 4,228,337
Accrued compensation and benefits 1,306,906 919,825
Accrued interest payable 1,486,041 1,347,787
Excise tax payable 1,167,173 1,167,173
Total current liabilities 17,464,283 16,908,870
Loans payable - non-current portion 300,000 300,000
Total non-current liabilities 300,000 300,000
Total liabilities 17,764,283 17,208,870
Stockholders' Equity:
Preferred stock ($0.0001 par value, 20,000,000 shares authorized)
Series A convertible preferred stock ($0.0001 par value, 110,000 shares designated, 0 and 0 issued and outstanding, respectively)
Series B convertible preferred stock ($0.0001 par value, 3,000 shares designated, 0 and 1 issued and outstanding, respectively)
Series C convertible preferred stock ($0.0001 par value, 5,000 shares designated, 2,547 and 4,851 issued and outstanding, respectively)
Series D convertible preferred stock ($0.0001 par value, 6,666,700 shares designated, 150,000 and 150,000 issued and outstanding, respectively) 15 15
Series E convertible preferred stock ($0.0001 par value, 100 shares designated, 51 and 51 issued and outstanding, respectively)
Series F convertible preferred stock ($0.0001 par value, 10,000 shares designated, 0 and 0 issued and outstanding, respectively)
Series G convertible preferred stock ($0.0001 par value, 10,000 shares designated, 143 and 143 issued and outstanding, respectively)
Common stock ($0.0001 par value, 300,000,000 shares authorized, 5,510,021 and 3,642,501 shares issued and outstanding, respectively) 551 364
Additional paid in capital 46,979,742 46,979,762
Accumulated deficit (29,007,543) (26,879,081)
Total stockholders' equity attributable to Cycurion 17,972,765 20,101,060
Deficit attributable to noncontrolling interests (4,290,918) (3,857,594)
Total stockholders' equity 13,681,847 16,243,466
Total liabilities and stockholders’ equity$31,446,130 $33,452,336


CYCURION, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(Unaudited)
For the Three Months Ended March 31,
March 31, 2026 March 31, 2025
Revenue$3,268,620 $3,870,050
Cost of revenue 2,580,262 3,192,287
Gross profit 688,358 677,763
Operating expenses:
Selling, general and administrative expenses 2,743,695 337,374
Stock compensation expenses 315,833
Business combination expenses 10,437,894
Total operating expenses 3,059,528 10,775,268
Operating loss (2,371,170) (10,097,505)
Other income/(expenses):
Interest income 14,236
Interest expense (204,852) (178,890)
Gain on debt settlement, net 141,653
Other expense, net (113,744)
Other expenses, net (190,616) (150,981)
Loss before income taxes (2,561,786) (10,248,486)
Provision for income tax
Net loss (2,561,786) (10,248,486)
Less: Net loss attributable to non-controlling interest 433,324
Net loss attributable to Cycurion$(2,128,462) $(10,248,486)
Comprehensive loss$(2,128,462) $(10,248,486)
Loss per share:
Basic$(0.47) $(15.57)
Diluted$(0.47) $(7.40)
Weighted average shares outstanding:
Basic 4,561,976 658,218
Diluted 4,561,976 1,383,507


CYCURION, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
For the Three Months Ended March 31,
2026 2025
Cash flows from operating activities:
Net loss$(2,561,786) $(10,248,486)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation 315,833
Stock-based compensation - business combination related 9,250,000
Amortization of debt discount 1,187 64,850
Depreciation of property and equipment 1,709
Amortization of software development costs 8,333
Gain on debt settlement, net (141,653)
Finance expense 100,000
Changes in assets and liabilities:
Accounts receivable, net and other receivables (648,568) (1,300,686)
Prepaid expenses and other current assets (46,801) (11,415)
Accounts payable and accrued liabilities (184,201) (286,114)
Accrued compensation and benefits 96,248 37,673
Accrued interest payable 138,254 (219,320)
Net cash used in operating activities (2,889,834) (2,745,109)
Cash flows from investing activities:
Cash acquired on business combination 34,983
Capitalized software development costs (129,000) (70,000)
Cash withdrawn from Trust Account in connection with redemption 1,001,216
Release of Trust Account to Company's bank account 833,324
Net cash (used in)/provided by investing activities (129,000) 1,799,523
Cash flows from financing activities:
Proceeds from exercise of warrants 167 3,309,921
Redemption of common stock subject to redemption (1,001,216)
Repayments of revolving line of credit (207,850) (9,300)
Repayment of bank borrowings (5,114)
Proceeds from convertible notes payable 386,500
Proceeds from notes payable 513,200
Repayments of notes payable (20,000)
Net cash (used in)/provided by financing activities (207,683) 3,173,991
Net (decrease)/increase in cash and cash equivalents (3,226,517) 2,228,405
Cash and cash equivalents, beginning of period 5,255,235 40,790
Cash and cash equivalents, end of period$2,028,718 $2,269,195



Source: Cycurion

Categories

Globe Newswire Press Releases